Original Articles
7 March 2013
Vol. 5 No. 3 (2011)
Impact of NSAIDs on cardiovascular risk and hypertension
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1089
Views
1136
Downloads
Authors
Materials and methods: In this brief review, the focus is on both effects of the NSAIDs and COX-2 inhibitors on blood pressure and CV events. The literature was searched using PubMed for both clinical trials and observational studies reviewing the relations among NSAIDs, blood pressure, and CV events.
Results: Clinical trial results for NSAIDs and COX-2 inhibitors have shown varying levels of destabilization of blood pressure control in treated hypertensive patients as well as variable incident rates of the development of arrhythmias, congestive heart failure, myocardial infarction, and stroke.
Discussion: The non-selective and COX-2 selective NSAIDs can be used with care in selected arthritis patients with hypertension and stable CV disorders (excluding congestive heart failure and moderate to severe kidney dysfunction) when the individual clinical benefit of antiinflammatory therapy outweighs the CV and gastrointestinal risk.
Altmetrics
Downloads
Download data is not yet available.
Citations
How to Cite
Impact of NSAIDs on cardiovascular risk and hypertension. (2013). Italian Journal of Medicine, 5(3), 175-183. https://doi.org/10.4081/itjm.2011.175
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.